Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Chembl3809216
2. Schembl16903728
3. Dtxsid301336530
| Molecular Weight | 355.5 g/mol |
|---|---|
| Molecular Formula | C22H29NO3 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 355.21474379 g/mol |
| Monoisotopic Mass | 355.21474379 g/mol |
| Topological Polar Surface Area | 60.8 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 566 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
48
PharmaCompass offers a list of KLS-13019 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right KLS-13019 manufacturer or KLS-13019 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred KLS-13019 manufacturer or KLS-13019 supplier.
PharmaCompass also assists you with knowing the KLS-13019 API Price utilized in the formulation of products. KLS-13019 API Price is not always fixed or binding as the KLS-13019 Price is obtained through a variety of data sources. The KLS-13019 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A KLS-13019 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of KLS-13019, including repackagers and relabelers. The FDA regulates KLS-13019 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. KLS-13019 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A KLS-13019 supplier is an individual or a company that provides KLS-13019 active pharmaceutical ingredient (API) or KLS-13019 finished formulations upon request. The KLS-13019 suppliers may include KLS-13019 API manufacturers, exporters, distributors and traders.
KLS-13019 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of KLS-13019 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right KLS-13019 GMP manufacturer or KLS-13019 GMP API supplier for your needs.
A KLS-13019 CoA (Certificate of Analysis) is a formal document that attests to KLS-13019's compliance with KLS-13019 specifications and serves as a tool for batch-level quality control.
KLS-13019 CoA mostly includes findings from lab analyses of a specific batch. For each KLS-13019 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
KLS-13019 may be tested according to a variety of international standards, such as European Pharmacopoeia (KLS-13019 EP), KLS-13019 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (KLS-13019 USP).
